Scioderm.

PositionStatewide: TRIANGLE REGION

DURHAM -- Cranbury, N.J.-based Amicus Therapeutics will acquire Scioderm for $229 million. The amount of the deal could reach $947 million if Scioderm's treatments meet certain clinical and regulatory milestones. Founded in 2013, Scioderm makes...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT